CTOs on the Move

908 Devices

www.908devices.com

 
908 Devices, is democratizing chemical analysis by way of mass spectrometry, offering point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. These purpose-built and user-centric devices serve a range of industries including safety and security, oil & gas, life sciences and other applied markets. 908 Devices is headquartered in the heart of Boston where they research, design and manufacture innovative products based on High Pressure Mass Spectrometry (HPMS).
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Skye Grams
Director Of Information Technology Profile

Funding

908 Devices raised $12M on 05/06/2015
908 Devices raised $20M on 03/15/2017
908 Devices raised $17.5M on 04/29/2019

Similar Companies

Open Mri Of Macon

Open Mri Of Macon is a Macon, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medsource Diagnostics

Medsource Diagnostics is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ECI MEDICAL TECHNOLOGIES

ECI MEDICAL TECHNOLOGIES INC. is a Bridgewater, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioData Medical Laboratories

BioData Medical Laboratories is a Montclair, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Duke Clinical Research Institute

As part of the Duke University School of Medicine, the Duke Clinical Research Institute is known for conducting groundbreaking multinational clinical trials, managing major national patient registries, and performing landmark outcomes research. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI also is home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding. Our mission is to develop and share knowledge that improves the care of patients around the world through innovative clinical research.